About Tandem Diabetes Care
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: TNDM
- Previous Close: $2.40
- 50 Day Moving Average: $2.38
- 200 Day Moving Average: $4.54
- 52-Week Range: $30,642,000.00 - $1.60
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.09
- P/E Growth: -0.03
- Market Cap: $75.07M
- Outstanding Shares: 30,642,000
- Beta: 0.5
- Net Margins: -95.57%
- Return on Equity: -220.14%
- Return on Assets: -72.51%
Companies Related to Tandem Diabetes Care:
- Debt-to-Equity Ratio: 8.61%
- Current Ratio: 2.04%
- Quick Ratio: 1.38%
What is Tandem Diabetes Care's stock symbol?
Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."
Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2017?
9 brokerages have issued twelve-month price targets for Tandem Diabetes Care's shares. Their forecasts range from $3.50 to $12.00. On average, they expect Tandem Diabetes Care's share price to reach $7.75 in the next twelve months.
When will Tandem Diabetes Care announce their earnings?
Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Wednesday, February, 22nd 2017.
What are analysts saying about Tandem Diabetes Care stock?
Here are some recent quotes from research analysts about Tandem Diabetes Care stock:
According to Zacks Investment Research, "Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California. " (1/18/2017)
Robert W. Baird analysts commented, "We’re dialed into the low end of the guidance, since many observers have commented to us on the ramp throughout 2016. LPNT previously guided to 100bps of margin improvement in 2017. On that basis, the stock sells for 6.4x EBITDA, below trough levels. LPNT’s SS IP admits are likely to be challenged, but we think that’s fairly reflected in the current narrative and sector-low valuation. 1Q recap: Soft volumes, slight miss, good cost controls. Reported revs of $1.581b beat consensus at $1.566b by 0.9%. EBITDA of $186m was $1m or 0.4% shy of consensus. Adjusted EPS of $0.87 missed by a penny, but excludes $0.02 of accelerated D&A from Marquette. While a recurring and real expense, we’ve excluded it from our model to make our estimates consistent with management’s guidance." (5/2/2016)
Who owns Tandem Diabetes Care stock?
Tandem Diabetes Care's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Frontier Capital Management Co. LLC (3.57%), Renaissance Technologies LLC (0.99%), Eventide Asset Management LLC (0.90%), State Street Corp (0.76%), Keybank National Association OH (0.23%) and Wrapmanager Inc. (0.20%). Company insiders that own Tandem Diabetes Care stock include Dick Allen and John F Sheridan.
Who sold Tandem Diabetes Care stock? Who is selling Tandem Diabetes Care stock?
Tandem Diabetes Care's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Frontier Capital Management Co. LLC.
Who bought Tandem Diabetes Care stock? Who is buying Tandem Diabetes Care stock?
Tandem Diabetes Care's stock was acquired by a variety of institutional investors in the last quarter, including A.R.T. Advisors LLC, First Republic Investment Management Inc., Wrapmanager Inc., Keybank National Association OH and State Street Corp.
How do I buy Tandem Diabetes Care stock?
Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Tandem Diabetes Care stock cost?
One share of Tandem Diabetes Care stock can currently be purchased for approximately $2.45.